I want to look at the phosphorylation of AKT in HUVECs treated with hyperglycaemia. Can anyone suggest whether I should use the pAKT Ser473 or Thr308 antibody? Does it matter which one of the phosphorylated isoforms I use? Thanks
Since it seems like you are more interested in the effect of the mTOR pathway on AKt thank the PI3K pathway (assumed because you are using hyperglycaemia treatment) I would suggest using the Ser473 antibody as this is the direct target of mTORC2.